• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

择期经皮冠状动脉介入治疗中的与操作相关的出血。

Procedure-related bleeding in elective percutaneous coronary interventions.

机构信息

Deutsches Herzzentrum, Technische Universität, Munich, Germany.

出版信息

Eur J Clin Invest. 2015 Mar;45(3):263-73. doi: 10.1111/eci.12408. Epub 2015 Feb 14.

DOI:10.1111/eci.12408
PMID:25645583
Abstract

BACKGROUND

Prognostic impact of procedure-related bleeding in patients with stable coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI) remains incompletely investigated. The aim of this study was to investigate the association between peri-PCI bleeding and 1-year outcome of patients with stable CAD.

MATERIALS AND METHODS

The study included 9035 patients with stable CAD who underwent elective PCI. Bleeding within 30 days of PCI was defined using the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 1-year mortality.

RESULTS

Bleeding occurred in 844 patients (9.3%). Actionable bleeding (BARC class ≥ 2) occurred in 442 patients (4.9%). There were 210 deaths (2.3%) at 1 year following PCI: 41 deaths among patients with bleeding and 169 deaths among patients without bleeding [Kaplan-Meier estimates of mortality, 4.9% and 2.1%; odds ratio = 2.41, 95% confidence interval (CI) 1.73-3.36, P < 0.001]. The association between bleeding and mortality remained significant after adjustment for baseline risk variables (adjusted hazard ratio = 1.87, 95% CI 1.27-2.76, P = 0.002). Bleeding increased the discriminatory power of the model regarding prediction of 1-year mortality (absolute and relative integrated discrimination improvement, 0.006% and 16.3%, respectively, P = 0.001).

CONCLUSIONS

In patients with stable CAD undergoing elective PCI, the occurrence of bleeding within 30 days of the procedure was associated with increased risk of death at 1 year after PCI. These findings suggest that procedure-related bleeding may contribute to less than optimal results of PCI in terms of mortality reduction in patients with stable CAD.

摘要

背景

在接受择期经皮冠状动脉介入治疗(PCI)的稳定型冠状动脉疾病(CAD)患者中,与操作相关的出血对预后的影响仍未得到充分研究。本研究旨在探讨稳定型 CAD 患者 PCI 围术期出血与 1 年预后的关系。

材料与方法

本研究纳入了 9035 例接受择期 PCI 的稳定型 CAD 患者。使用 Bleeding Academic Research Consortium(BARC)标准定义 PCI 术后 30 天内出血。主要终点为 1 年死亡率。

结果

844 例(9.3%)患者发生出血。有 442 例(4.9%)患者发生可操作性出血(BARC 分级≥2)。PCI 后 1 年发生 210 例死亡(2.3%):出血患者 41 例,无出血患者 169 例[死亡率的 Kaplan-Meier 估计值分别为 4.9%和 2.1%;比值比=2.41,95%置信区间(CI)为 1.73-3.36,P<0.001]。在校正基线风险变量后,出血与死亡率之间的相关性仍然显著(调整后危险比=1.87,95%CI 为 1.27-2.76,P=0.002)。出血增加了模型对 1 年死亡率预测的区分能力(绝对和相对综合判别改善分别为 0.006%和 16.3%,P=0.001)。

结论

在接受择期 PCI 的稳定型 CAD 患者中,术后 30 天内发生出血与 PCI 后 1 年死亡风险增加相关。这些发现表明,在稳定型 CAD 患者中,与操作相关的出血可能导致 PCI 在降低死亡率方面的效果不理想。

相似文献

1
Procedure-related bleeding in elective percutaneous coronary interventions.择期经皮冠状动脉介入治疗中的与操作相关的出血。
Eur J Clin Invest. 2015 Mar;45(3):263-73. doi: 10.1111/eci.12408. Epub 2015 Feb 14.
2
Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.根据出血学术研究联盟分类的院内出血对接受经皮冠状动脉介入治疗患者长期不良结局的影响
Catheter Cardiovasc Interv. 2015 Jan 1;85(1):63-71. doi: 10.1002/ccd.25308. Epub 2014 Jul 30.
3
Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.慢性肾脏病患者经皮冠状动脉介入治疗中出血的发生率及其对预后的影响。
Clin Res Cardiol. 2014 Jan;103(1):49-56. doi: 10.1007/s00392-013-0622-x. Epub 2013 Oct 4.
4
Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.验证在接受经皮冠状动脉介入治疗的冠心病患者中使用 Bleeding Academic Research Consortium 定义的出血标准。
Circulation. 2012 Mar 20;125(11):1424-31. doi: 10.1161/CIRCULATIONAHA.111.060871. Epub 2012 Feb 17.
5
Correlates of poor outcome among patients with bleeding after coronary interventions.冠状动脉介入治疗后出血患者预后不良的相关因素。
Coron Artery Dis. 2014 Sep;25(6):456-62. doi: 10.1097/MCA.0000000000000126.
6
Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age.> 75 岁以上经皮冠状动脉介入治疗患者的出血发生率及预后价值。
Catheter Cardiovasc Interv. 2014 Feb;83(2):182-9. doi: 10.1002/ccd.25189. Epub 2013 Oct 19.
7
Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.在年龄、体重指数和抗血栓治疗类型匹配的女性和男性中,经皮冠状动脉介入治疗后的出血。
Am Heart J. 2013 Sep;166(3):534-40. doi: 10.1016/j.ahj.2013.07.006. Epub 2013 Aug 6.
8
Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.在未选择患者中,经皮冠状动脉介入治疗后的围手术期出血和心肌梗死对预后的影响:来自 EVENT(药物洗脱支架和缺血事件评估)登记处的结果。
JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82. doi: 10.1016/j.jcin.2009.09.002.
9
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial.依诺肝素与普通肝素在择期经皮冠状动脉介入治疗中的比较:STEEEPLE 试验(依诺肝素在经皮冠状动脉介入治疗患者中的安全性和疗效的国际随机评价)1 年结果。
JACC Cardiovasc Interv. 2009 Nov;2(11):1083-91. doi: 10.1016/j.jcin.2009.08.016.
10
Increased bleeding risk during percutaneous coronary interventions by arterial hypertension.动脉高血压导致经皮冠状动脉介入治疗期间出血风险增加。
Catheter Cardiovasc Interv. 2016 Aug;88(2):184-90. doi: 10.1002/ccd.26272. Epub 2015 Nov 3.

引用本文的文献

1
Meta-Analysis of Short vs. Prolonged Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation and Role of Continuation with either Aspirin or a P2Y Inhibitor Thereafter.药物洗脱支架置入后短期与长期双联抗血小板治疗的荟萃分析及此后继续应用阿司匹林或 P2Y 抑制剂的作用
J Atheroscler Thromb. 2022 Jul 1;29(7):1001-1019. doi: 10.5551/jat.63000. Epub 2021 Jul 10.